Creators and Guests

Heath Fletcher
Host
Heath Fletcher
With over 30 years in creative marketing and visual storytelling, I’ve built a career on turning ideas into impact. From brand transformation to media production, podcast development, and outreach strategies, I craft compelling narratives that don’t just capture attention—they accelerate growth and drive measurable results.
Appears in 74 episodes
Adityo Prakash
Guest
Adityo Prakash
Adityo Prakash is a scientist-entrepreneur and the Founder & CEO of Verseon, where he is transforming drug discovery and development through Deep Quantum Modeling and AI. Driven by the belief that current methods limit the medicines the world can create, he built Verseon to systematically design therapeutics previously out of reach and elevate the standard of care across major diseases. Before Verseon, he founded Pulsent Corporation, developing foundational technologies that power modern video streaming. His work across physics, computation, and engineering has produced more than 40 patent families, and he holds a BS in Physics and Mathematics from Caltech.
Appears in 1 episode
Aimee Taylor
Guest
Aimee Taylor
Aimee Taylor is the founder and CEO of Alt Digital Marketing, a company that specializes in medical marketing with particular emphasis on the aesthetics industry. Aimee has over 13 years of digital marketing experience, which is bolstered by two decades of broadcast TV sales. She has a deep understanding of all aspects of digital and traditional marketing. She has a BA in Telecommunications from Indiana University, Bloomington, IN.
Appears in 1 episode
Anna Forsythe
Guest
Anna Forsythe
Anna Forsythe, PharmD, MBA, is the Founder and CEO of Oncoscope-AI, the first platform to unify real-time oncology treatment data, clinical guidelines, research, and regulatory approvals—offered free to oncology professionals worldwide and often described as “Expedia for cancer care.” With a background spanning pharmacy, health economics, and executive leadership at Novartis, Bayer, and Eisai, Anna previously co-founded Purple Squirrel Economics (acquired by Cytel in 2020), has taught health economics at Long Island University, and is a frequent industry speaker and author, with her 2022 JAMA Pediatrics article on conversion therapy ranked in the top 5% of all JAMA research outputs worldwide.
Appears in 1 episode
Annie Stephanos
Guest
Annie Stephanos
Annie Stephanos, M.Ed., CMHC, CPLC is a life, mental health, and wellness coach who helps individuals reconnect with themselves and build sustainable paths to balance and well-being. A former educational coach and Founder of Highroads Coaching, she empowers clients to recognize that the capacity for meaningful change has been within them all along. Annie brings a deep passion for guiding people toward their goals, grounded in her core values of hope, trust, and compassion, shaped by her own journey through burnout and PTSD.
Appears in 1 episode
Ataes Aggarwal
Guest
Ataes Aggarwal
Ataes Aggarwal is the co-founder of Moodr Health, a company empowering healthcare organizations to build genuine, scalable connections with their patients through AI-driven, ethical technology. A Johns Hopkins Biomedical Engineering graduate, Ataes combines technical expertise with empathy to advance behavioral health. He champions responsible AI, emphasizing privacy, fairness, and respect, and believes success comes from simplicity, perseverance, and creating real impact in people’s lives.
Appears in 1 episode
Bill Wittmeyer
Guest
Bill Wittmeyer
Bill Wittmeyer is the Founder and CEO of Maggie’s Breath (formerly Pulmostics Limited) where he applies advanced detection technologies—such as high-speed gas chromatography—to protect human health and the environment. Maggie’s Breath was renamed in honour of Bill’s late wife, Maggie, who lost her battle with breast cancer while working to advance life-saving diagnostics. Her vision lives on through the company’s mission: to create a revolutionary, non-invasive breath-based screening tool that can detect disease early and save lives. Bill’s leadership spans innovations in healthcare, environmental monitoring, and public safety, all driven by a commitment to turning personal loss into global impact for a healthier, more sustainable world.
Appears in 1 episode
Braden Pan
Guest
Braden Pan
The idea for Resolve was sparked in 2016, when founder Braden Pan received an outrageous hospital bill for a brief, 15-minute consultation. Frustrated by the complex and opaque billing process, Braden set out to find a better way. That experience became the foundation for Resolve—a company dedicated to helping Americans fight back against unfair medical bills. Since then, Resolve has tackled all types of healthcare billing challenges, partnering with experts across the healthcare ecosystem to reduce financial stress and bring greater transparency to the system.
Appears in 1 episode
Brent Lucas
Guest
Brent Lucas
Brent Lucas is CEO and Board Member of Envoy Medical, an early-stage medical device company pioneering fully implanted hearing solutions, including the Esteem® active middle ear implant and the investigational Acclaim® cochlear implant. A principled medical device executive with a legal background, Brent brings 15+ years of leadership across enterprise functions—spanning strategy, finance, compliance, stakeholder engagement, and product development. Known for his transparent and motivating leadership style, he has guided Envoy through organizational turnaround, fundraising, and global commercialization efforts. With a track record of building inspired teams, streamlining operations, and driving patient-focused innovation, Brent is dedicated to improving quality of life through breakthrough medical technologies.
Appears in 1 episode
Bret Larsen
Guest
Bret Larsen
Bret Larsen is the Founder and CEO of Chief, a sales performance management platform built to help modern sales teams turn complexity into clarity and make growth inevitable. A 3x founder and seasoned CEO, Bret has built multiple high-growth B2B software companies recognized by Inc. 5000, Deloitte Fast 500, Forrester, and Gartner. Named a Titan 100 CEO, Top 50 CEO in Healthcare Technology, and Ernst & Young Entrepreneur of the Year finalist, he’s known for building high-performing teams and market-defining products. Backed by investors including Goldman Sachs and Kickstart Seed Fund, Bret also advises startups and serves on boards across technology, healthcare, and education.
Appears in 1 episode
Brian Newsom
Guest
Brian Newsom
Brian Newsom is the founding CEO of the vector technology company, Carrigent, as well as the VP of Business Development for the cell therapy CDMO, Theragent. Prior to this, Brian spent six years at KBI Biopharma and almost a decade at Thermo Fisher Scientific (and legacy companies) in business development. Brian’s technical background includes posts as Head of R&D at Opexa Therapeutics and five years at Baylor College of Medicine, Center for Cell and Gene Therapy. Brian began his career in cell therapy at Aastrom Biosciences, one of the industries pioneering companies, in 1992. Brian received his degree in Microbiology from Texas Tech University and an MBA from Texas A&M University.
Appears in 1 episode
Chandima  Bandara
Guest
Chandima Bandara
Chandima Bandara is CEO of Precision Quantomics, where he leads the company’s mission to transform drug development through high-precision proteomics. With more than 20 years of experience across biotechnology, contract research, business development, and large-scale operations, he brings a unique blend of scientific expertise and operational leadership to the biotech industry. He began his career in R&D before scaling growth at a leading CRO and later managing world-class logistics operations at Amazon. Over the past six years, he has focused on commercializing scientific innovation through life sciences startups. At Precision Quantomics, he is building a comprehensive proteomics database, LC-MS kit portfolio, and testing-as-a-service platform to accelerate pharmaceutical R&D and reduce costs. Chandima also serves on the Board of Trustees for the Health Sciences & Services Authority of Spokane County and contributes to national initiatives advancing regulatory science and New Approach Methodologies.
Appears in 1 episode
Chris Dayton
Guest
Chris Dayton
Chris Dayton is the Co-Founder and CEO of Quality Assured Ai, a company delivering closed-system, on-premise AI solutions purpose-built for pharmaceutical Quality Assurance and Quality Management. With over a decade of experience across protein, cell, and gene therapy manufacturing, he has served as a lead investigator, QMS author, and technical operations manager overseeing QDS authorship and validation approvals. Chris has designed and deployed AI/ML models that streamline deviation drafting, SOP generation, and CAPA support while maintaining strict compliance with FDA, EMA, and MHRA regulatory frameworks. He has consulted with top-25 global pharmaceutical companies on GxP-aligned AI pilots and is a recognized thought leader in AI governance for life sciences, speaking at PDA events and leading AI literacy initiatives for QA and regulatory professionals.
Appears in 1 episode
Dan Goldberger
Guest
Dan Goldberger
Dan Goldberger is a highly accomplished C-level executive with over 25 years of leadership experience, known for driving revenue growth and organizational success in the life sciences and healthcare sectors. He has built a strong reputation for leading turnaround initiatives, cultivating high-performance cultures, and spearheading product innovation in competitive, highly regulated industries including biotech, high tech, and medical technology. While his résumé outlines an impressive history of roles and achievements, it does not fully capture the perseverance and dedication he brings to every opportunity. A lifelong contributor to the life sciences and healthcare space, Dan is deeply committed to developing companies and products that improve and save lives—an enduring passion that motivates him to build exceptional teams, processes, and systems that deliver meaningful impact.
Appears in 1 episode
David Esposito
Guest
David Esposito
David Esposito is an experienced health care executive who has built and scaled multiple companies, resulting in successful exits to strategic buyers. He is the former CEO of Armune BioScience, where he led the development and commercialization of blood-based diagnostics to improve the early detection of cancer. The company successfully launched the only non-PSA blood test to improve the detection of prostate cancer. Armune BioScience was sold to Exact Sciences (EXAS) in 2017. David was president of Phadia US Inc. (allergy and autoimmune diagnostics) and played a pivotal role in the sale of the business to Thermo Fisher Scientific (TMO) in 2011. He began his career as a sales representative with Merck & Co. Inc., rising through the ranks of sales, marketing and commercial strategy for the U.S. division. As a combat veteran, David led an infantry platoon with the 101st Airborne Division through several combat operations and was recognized with a Bronze Star for combat action in Iraq in 1991. He earned his bachelor’s degree in civil engineering from the U.S. Military Academy at West Point and his MBA from Syracuse University.
Appears in 1 episode
David Georges
Guest
David Georges
David Georges has been a global business leader in Breast Imaging for the past twenty-five years, contributing to the introduction and substantial market growth of innovative products dedicated to the early detection of breast cancer including mammography, breast biopsy, computer aided detection, breast ultrasound and automated breast ultrasound. David has established manufacturing sites, supported luminary sites for new product introduction, and established physician and technologist training centers. He has held senior executive positions in companies such as Transworld, Lorad, Hologic, R2, SuperSonic Imagine, iVu and U-systems; the latter of which was purchased by GE. Since joining Koning, David has led the effort to move the company from a Research and Development group to one that is prepared for commercializing Koning’s KBCT. David’s industry relationships have introduced opportunities to establish critically important luminary partners. With a knowledge of global distribution, David has expanded the Koning installation base to Thailand, Qatar, and Netherlands.
Appears in 1 episode
Doug Cohen
Guest
Doug Cohen
Doug Cohen is IR Medtek's Co-Founder and CEO and has over 20 years of experience in manufacturing equipment, product design, global sourcing, and logistics. Doug is a graduate of MIT in mechanical engineering and has experience as both an owner and investor in start-ups. He owns a number of technology patents and serves on the board of the public company Organovo.
Appears in 1 episode
Dr. Alena Butkevica
Guest
Dr. Alena Butkevica
Dr. Alena Butkevica, MD, DMD, PhD, is an Oral and Maxillofacial Surgeon and specialist in Prosthodontics and Implantology with over 28 years of clinical experience and more than 15,000 surgical procedures performed; she is also the CEO and founder of AB BIOINNOVATIONS, Inc. (AB BIO), a U.S.-based biotechnology company developing science-backed products that reset, restore, and enhance the body’s natural regenerative abilities by improving circulation, releasing toxins, and accelerating healing—an approach rooted in Dr. Butkevica’s 19 years of scientific research in fast and healthy tissue regeneration.
Appears in 1 episode
 Dr. April Joy Damian
Guest
Dr. April Joy Damian
Dr. April Joy Damian is an epidemiologist and health services researcher specializing in health equity, social determinants of health, and psychiatric epidemiology. She serves as Chief Scientific Officer and Director of the Weitzman Institute, leading research, education, and policy efforts to advance quality improvement and primary care transformation for vulnerable populations. Dr. Damian is also a Senior Scholar for Health Equity at Academy Health and holds faculty appointments at Johns Hopkins Bloomberg School of Public Health and Wesleyan University. A national thought leader, she contributes to multiple advisory boards and committees, including the National Academies and NIH’s RECOVER initiative. Previously, she directed Quality Innovation at the National Quality Forum, expanding efforts around social determinants of health measurement. Dr. Damian earned her PhD from Johns Hopkins, a master’s from Harvard Medical School, and her bachelor’s degree with highest honors from UC Berkeley.
Appears in 1 episode
Dr. Axa Yox
Guest
Dr. Axa Yox
Dr. Axa Yox is a former scientist turned transformational speaker, author, and LinkedIn strategist. With a PhD in Microbiology and Genetics and a career marked by international fellowships and groundbreaking research, she has authored over 45 scientific papers and holds 12 inventions. Now based in Miami, she’s the founder of X Theory, host of the W.H.Y. – What How Y podcast, and author of Foolfilled Life, a motivational guide to rewiring the brain to overcome anxiety and procrastination. A TEDx 2025 speaker-in-prep and executive contributor at BRAINZ Magazine, Axa brings deep scientific insight to personal development, branding, and the psychology of change.
Appears in 1 episode
Dr. Ethan Perlstein
Guest
Dr. Ethan Perlstein
Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs and discovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.
Appears in 1 episode
Dr. Harsha K. Rajasimha
Guest
Dr. Harsha K. Rajasimha
Dr. Harsha K. Rajasimha is a scientist, entrepreneur, and patient advocate, and the Founder & CEO of Jeeva Clinical Trials—an AI-driven platform making clinical research more efficient and accessible worldwide. He also serves as Founder and Chair of the Indo US Organization for Rare Diseases, building global collaboration to improve outcomes for patients with rare conditions. Motivated by personal loss, Harsha has dedicated his 20-year career in precision medicine and biotech to advancing rare disease research, patient advocacy, and the use of technology to accelerate clinical trials.
Appears in 1 episode
Dr. Josh Funk
Guest
Dr. Josh Funk
Dr. Josh Funk is the Founder and CEO of Rehab 2 Perform (R2P), a growing performance-based physical therapy company redefining how people experience rehab and recovery. With a model rooted at the intersection of movement, mindset, and long-term performance, Dr. Funk and his team focus on helping clients—from athletes and new moms to first responders and everyday movers—level up, not just heal. Under his leadership, R2P has grown into a multi-location, multi-state business that blends clinical excellence with a community-driven culture. The core philosophy? Treat people like athletes, build a better baseline, and help them perform for life. Dr. Funk also co-leads R2P Academy, an education and mentorship platform for clinicians, intrapreneurs, and future leaders in performance healthcare. A frequent speaker on topics like growth strategy, identity-based care, and scaling with soul, Dr. Funk is passionate about building businesses that make a lasting impact—inside and outside the clinic.
Appears in 1 episode
Dr. Kevin Scanlon
Guest
Dr. Kevin Scanlon
Dr. Kevin Scanlon is a seasoned leader in life sciences, with a career spanning academic medicine, executive roles in biotech and pharma, and active angel investing. Recognized by LA Techweek for his impact on the Los Angeles tech and business landscape, he served as Chairman of the Pasadena Angels, where nearly 100 investors funded over 50 companies during his tenure. Dr. Scanlon has led four biotech companies as CEO, including Melanoma Diagnostics, acquired by Myriad Genetics. At Berlex-Schering AG, he oversaw global genomic and oncology programs across the US, Europe, and Asia. His academic credentials include being a Leukemia Society Scholar, recipient of the Paul Martini Medical Research Prize (Germany), and co-founding editor of Cancer Gene Therapy (Nature Publishing Group). He has served as President of the International Society of Cell and Gene Therapy and authored 139 peer-reviewed papers, nine medical books, and seven U.S. patents. Dr. Scanlon is also the author of The Hybrid Entrepreneur.
Appears in 1 episode
Dr. Marsha L. Hartman
Guest
Dr. Marsha L. Hartman
Dr. Marsha L. Hartman is the Fractional CEO of Exodigm Biosciences, a pioneering startup within the General Inception portfolio. At Exodigm, she is leading efforts to revolutionize cellular biology by enabling live single-cell analysis through transcriptomic insights — helping researchers and biomanufacturers work precisely with the cells they need. With a background in epidemiology and extensive leadership experience across diagnostics, biotech, and commercialization, Dr. Hartman brings a strategic and scientific lens to building scalable solutions for the next generation of cell therapy and analysis. Under her leadership, Exodigm is pushing the boundaries of innovation to accelerate discovery and redefine what’s possible in cellular science.
Appears in 1 episode
Dr. Merle Griff
Guest
Dr. Merle Griff
Merle D. Griff, Ph.D. is the Founder & CEO of SarahCare and one of the leading authorities on senior care in the United States. She has served in national leadership roles including Past Chair of the National Adult Day Services Association (NADSA), member of CARF’s International Advisory Board, and as a federal task force contributor to the U.S. Department of Aging. A former play therapist, Dr. Griff developed widely adopted Family Play Therapy and Intergenerational Play Therapy models and is the author of Linkages, along with numerous scholarly publications. She also hosts the podcast Caught Between Generations, focused on the challenges facing caregivers in the sandwich generation.
Appears in 1 episode
Dr. Paula Muto
Guest
Dr. Paula Muto
UBERDOC Founder and CEO Paula M. Muto, MD FACS, is a practicing vascular and general surgeon in solo practice and the owner of Muto Vein Center. She is a member of a family of physicians and surgeons who have collectively practiced medicine in Massachusetts for over 50 years. She is an outspoken advocate for patient care and is passionate about women’s health issues.
Appears in 1 episode
Dr. Psyche Young
Guest
Dr. Psyche Young
Psyche Young, Ph.D., LPC is a licensed psychotherapist, consultant, and public speaker with over a decade of clinical experience supporting individuals, couples, and families. She is the Owner and CEO of YaH Vision Counseling & Wellness LLC and Co-Founder of YaH Vision Productions, with a particular focus on marriage and family therapy and working with military families navigating complex life transitions. A recognized thought leader in mental health, Dr. Young empowers clients to overcome barriers to personal and professional growth while building emotional resilience and sustainable wellness strategies. She is an engaging speaker and trusted consultant known for blending clinical expertise with real-world application. Dr. Young is a member of the American Association for Marriage and Family Therapy (AAMFT) and the American Counseling Association (ACA) and is guided by a core belief that wellness is not a privilege — it’s a human right.
Appears in 1 episode
Dr. Tia Warrick
Guest
Dr. Tia Warrick
Dr. Tia Warrick is the CEO of Lesous Consulting, a professional development, training, and technology solutions firm advancing excellence in clinical research and healthcare education. A Certified Global Project Manager with over seven years of experience in the industry, she brings expertise in strategic business analytics, AI software development, e-learning design, epidemiology (including RWE/HEOR), clinical data management, and public health consulting. An award-winning author of “Burst the Bubble: A Look into Careers in the Pharmaceutical Industry,” Dr. Warrick earned her Doctor of Health Science in Clinical Health Education from the University of Bridgeport. With a background in epidemiology and global clinical trials, she is dedicated to bridging gaps across healthcare, research, and education—mentoring the next generation of professionals and driving innovation that promotes equity, collaboration, and impact.
Appears in 1 episode
Dylan McDonnell
Guest
Dylan McDonnell
Dylan McDonnell is the Founder and CEO of Foodini, a foodtech platform connecting the 1 in 3 people with dietary needs to restaurants and menu items suitable for them through a dietitian-led verification model. Motivated by his own experience with Celiac disease, Dylan is focused on building technology that bridges the gap between consumers with dietary requirements and the hospitality industry. Under his leadership, Foodini has gained international recognition, including Startup of the Year (2022) from the International Association of Corporate Counsel and FoodTech CEO of the Year – Australia (2023) from APAC Insider.
Appears in 1 episode
Ed Fleischer
Guest
Ed Fleischer
Ed Fleischer is a Quality Control executive with extensive experience leading quality improvement, operational excellence, and compliance initiatives in the biotechnology industry. He brings deep knowledge of biotechnology processes, quality systems, and both domestic and international regulatory requirements. Ed has a strong background in Quality and has worked closely with regulatory agencies including the FDA, EMA, and others. He is also a dedicated leader who prioritizes the development of staff at all levels of the organization.
Appears in 1 episode
Eitan Akirav
Guest
Eitan Akirav
Eitan Akirav is a seasoned biotech leader with over 17 years of experience bridging scientific innovation and business strategy. From leading global biomarker programs at Cerba Research to launching rapid COVID-19 diagnostics at Enzo, he’s driven impactful solutions across the biotech and healthcare landscape. Earlier in his career at NYU, he secured multimillion-dollar research funding and led clinical trials in autoimmunity. With work featured in PNAS and Nature Immunology, Eitan continues to advance science at the intersection of research, innovation, and real-world application.
Appears in 1 episode
Elissa Zylbershlag
Guest
Elissa Zylbershlag
Elissa Zylbershlag, M.Ed. is the Founder of Work Wise Labs and a leadership development and team-building professional who helps nonprofits, universities, and small organizations create healthier, more connected workplaces. Through proactive coaching, interactive workshops, and culture-focused training, she works 1:1 with leaders and facilitates engaging group sessions that strengthen communication, trust, confidence, and collaboration—always with a focus on making work both productive and enjoyable. Through Work Wise Labs, Elissa equips organizations with practical tools to build supportive, mission-aligned cultures where people actually want to show up for work.
Appears in 1 episode
Erin Morrow
Guest
Erin Morrow
Erin Morrow is the Director of Product at Embark Veterinary, where she combines her passion for animals with cutting-edge technology to revolutionize pet care. With over 15 years of experience, she specializes in taking innovative products from initial concept through commercialization across SaaS, biotech, and educational technology sectors. Erin has a proven track record of building high-performing teams that consistently deliver products that users genuinely love. Her unique background includes a Bachelor's in Animal Science and Master's in Conservation Biology, giving her both the scientific rigor and deep empathy for animals and their caretakers that drives her customer-focused approach to product development.
Appears in 1 episode
Gautham Pasupuleti
Guest
Gautham Pasupuleti
Gautham Pasupuleti is the CEO and Managing Director of Biodesign Innovation Labs, a Bangalore- and Delaware-based medical device and healthcare company developing innovative and affordable critical care solutions. He leads a multidisciplinary team focused on life-saving technologies, including the patented RespirAID device, which supported hospitals across India during COVID-19. Gautham is a recognized innovator, having received awards such as Forbes India’s Ultimate 120 Pioneers of Change, the CISCO Global Problem Solver Pandemic Response Prize, and the Best Campus Startup Innovation Award from IIT Bombay. Previously, he was a researcher at MIT Media Lab and founded CornealX, an AI-based eye care startup now integrated into Biodesign Innovation Labs.
Appears in 1 episode
Georg Draude
Guest
Georg Draude
Georg Draude is a seasoned leader at the intersection of photonics, biotechnology, and advanced imaging. He currently serves as General Manager at Chroma Technology GmbH, where he has led commercial and market strategy since 2010. With a background spanning sales leadership, high-end imaging systems, and biomedical research, Georg brings a rare blend of scientific depth and market insight. He holds a doctorate in medical sciences from Ludwig-Maximilians-Universität München and has built his career translating complex technologies into real-world impact.
Appears in 1 episode
Griffin Fletcher
Editor
Griffin Fletcher
Griffin Fletcher is a Junior Project Manager who wears a lot of hats. He’s skilled in podcast and video editing, film production, cinematography, and social media management, bringing creativity and organization to every project he touches. Griffin also has a sports background—he’s worked in hockey analytics and as a referee—which sharpened his attention to detail and teamwork skills. With a BA in Economics, he mixes analytical thinking with a creative edge, making him a versatile and hands-on contributor to our team.
Appears in 36 episodes
Hadassah Jacobs
Guest
Hadassah Jacobs
Hadassah Jacobs is the Founder and CEO of Hadassah Jacobs International (HJI), a strategic launch and development studio helping visionaries turn ideas into successful ventures. With expertise in AI automation, biotech innovation, and digital strategy, she’s guided startups like Kotzker Phfarma from concept to emerging biopharmaceutical leader. Passionate about empowering women founders, Hadassah combines strategy, systems, and creativity to help entrepreneurs build impactful, scalable businesses.
Appears in 1 episode
James Lovgren
Guest
James Lovgren
As the CEO of Aspiro Therapeutics, James Lovgren leads the company’s mission to revolutionize the treatment of obstructive lung diseases with innovative CC16-inspired therapies. James is an accomplished life science executive with a distinguished track record of commercializing disruptive technologies and managing global product portfolios exceeding $250 million. His extensive background spans startups, growth-stage companies, and Fortune 150 biotechnology firms, where he has successfully brought a wide range of products, services, and reagents to market in the pharmaceutical, diagnostics, and life science sectors. James’ strategic insight and operational expertise are instrumental in guiding Aspiro Therapeutics through its preclinical development stage and beyond.
Appears in 1 episode
Jeffrey Petersen
Guest
Jeffrey Petersen
Jeffrey Petersen is the CEO and founder of Petersen Physical Therapy, launched with a mission to help as many people as possible move better and live healthier lives. With nearly four decades of experience, Jeff is deeply committed to clinical excellence and to building a welcoming, patient-centered environment that meets people exactly where they are and helps them move forward. He brings a rare blend of hands-on clinical insight, long-term leadership, and a genuine passion for helping patients recover, rehabilitate, and thrive.
Appears in 1 episode
Jessica Gibson
Guest
Jessica Gibson
Jessica Gibson is the CEO and Co-Founder of Ariel Precision Medicine, dedicated to delivering innovative technology to advance the art and science of Precision Medicine. Ariel leverages expert systems to accelerate precision medicine across the healthcare ecosystem by linking diagnostics and patient-centered data, uncovering the mechanisms of disease, and developing targeted treatments—fundamentally transforming patients' lives and outcomes. With a strong record of leadership, Jessica brings creative and solution-oriented problem-solving skills to accomplish strategic goals. At Ariel, she applies a broad range of experience across the pharmaceutical, biotechnology, clinical, and research sectors to develop scalable solutions for some of healthcare's most pressing challenges in chronic disease. Highly driven and grounded in a strong foundation of medical sales and marketing, Jessica is committed to collaborative engagement with diverse stakeholders, always with a patient-focused perspective.
Appears in 1 episode
Jessicca Rege
Guest
Jessicca Rege
Jessicca Rege is a pharmaceutical executive with extensive experience in oncology drug development, from pre-IND through commercialization. She has led R&D, regulatory, and medical affairs teams in both large pharma and biotech, guided in-licensing and acquisition strategies, and worked closely with global regulatory authorities. Jessica is also a trusted voice with investors, scientific leaders, and industry partners, advancing innovative cancer therapies worldwide.
Appears in 1 episode
Joe Banach
Guest
Joe Banach
Medical device sales professional that utilizes grit, achievement drive, and organization to achieve success and appropriate solutions for the customer. High achievement with highest revenue, President's Club, etc. Strong leadership skills and desire to facilitate the success of others.
Appears in 1 episode
John D. Marvin
Guest
John D. Marvin
John D. Marvin is a seasoned executive leader with more than three decades of experience developing people and organizations through intentional leadership, effective communication, and mindset-driven growth. As the former President and CEO of Texas State Optical, he guided one of the nation’s largest networks of independent optometric practices, steering the organization through industry change with strategic clarity, operational excellence, and a people-first approach. He believes the only limits we face are the ones we place on ourselves—and his mission is to help others rise above them, lead with purpose, and carry that belief forward.
Appears in 1 episode
Jonathan López
Guest
Jonathan López
Jonathan López is the Founder and CEO of karē Corp, a physician-trained entrepreneur focused on building regulated, science-first human performance systems. His work centers on the development of advanced subcutaneous infusion platforms that integrate pharmacology, hardware, and software to support human health and performance in demanding environments. Jonathan leads the company’s strategy across FDA-regulated development pathways, intellectual property creation, and dual-use deployment for civilian healthcare, first responders, defense, and space applications. He is currently advancing multiple patented platforms designed to align with federal innovation and research programs, with the goal of delivering next-generation biomedical solutions for extreme and mission-critical environments.
Appears in 1 episode
Katie Saindon
Guest
Katie Saindon
Katie Saindon is Senior Director of Product Management at Qventus, where she leads product strategy and execution for AI-driven healthcare solutions. An intrinsically motivated and passionate product leader, Katie brings global experience driving vision, roadmap, and delivery to generate revenue and elevate customer satisfaction. She’s known for balancing short- and long-term priorities with radical clarity—keeping outcomes front and center to deliver meaningful value for both customers and the business.
Appears in 1 episode
Kerchanin Allen
Guest
Kerchanin Allen
Throughout her career, Kerchanin Allen has supported organizations ranging from startups to Fortune 50 companies in operationalizing their marketing and communications strategies, with a focus on compliance and sustainable growth. In her recent roles, she has emphasized leadership in developing comprehensive, health-centric, and value-based marketing strategies that drive success in post-acute care and align with broader business objectives. Kerchanin works collaboratively with cross-functional teams to refine brand storytelling and develop robust, data-driven content pillars and account-based marketing (ABM) strategies that resonate with target audiences and support growth-focused initiatives. Her expertise also extends to leveraging data analytics for campaign optimization and managing budgets to maximize ROI. With a strong command of digital, print, and media channels, along with a talent for cultivating key partnerships, she plays a vital role in advancing brand presence and market influence.
Appears in 1 episode
Kevin Harris
Guest
Kevin Harris
Kevin Harris is the President and co-founder of CureMetrix. With over 25 years of leadership experience, Harris brings a demonstrated track record of success with particular expertise in new product ideation, implementation, market creation, and launch. As a strategic leader with deep operational expertise, Harris has led companies from inception through fundraising and mergers and acquisitions. At CureMetrix, Harris is responsible for envisioning the AI-based products and services tied to breast cancer and breast arterial calcifications detection that are the foundation of the company’s business and are the first of their kind in the world.
Appears in 1 episode
Kimberly Cremers
Guest
Kimberly Cremers
Kimberly Cremers is a licensed pharmacist, Certified Executive Coach, and seasoned Medical Affairs leader with over 25 years in the pharmaceutical and biotech industry. She has led teams across six companies and therapeutic areas, specializing in compliant, impactful scientific exchange with healthcare professionals. Kimberly brings a unique blend of strategic leadership, coaching, and humanitarian focus to every conversation.
Appears in 1 episode
 Larry L. Chism
Guest
Larry L. Chism
Larry L. Chism is a Senior Talent Acquisition Executive and entrepreneur with 25+ years of experience in full-cycle recruiting and strategic growth talent solutions. Throughout his career, Larry has placed hundreds of high-impact professionals—from junior contributors to C-suite leaders—across startups, Fortune 100 companies, and the biopharmaceutical and life sciences sectors. Notably, he has served in talent acquisition leadership roles supporting biopharma organizations, including Talent Acquisition at Rentschler Biopharma, where he focused on sourcing exceptional scientific, technical, and commercial talent in a highly competitive market.
Appears in 1 episode
Laura Lampa
Guest
Laura Lampa
Laura Lampa is the Founder and CEO of LML StoryLab Consulting, where she helps mission-driven companies in agriculture, fermentation, and sustainability tell compelling stories that inspire action. With over 18 years of experience spanning global organizations and startups—including Monsanto, Kaiser Permanente, Bayer Crop Science, and Ginkgo Bioworks—Laura brings a unique blend of scientific expertise and communications leadership. A former bench scientist turned strategist, she specializes in science communication, change management, and stakeholder engagement, empowering organizations to connect authentically and drive meaningful impact.
Appears in 1 episode
Laurence Bauer
Guest
Laurence Bauer
Laurence C. Bauer, M.S.W., M.Ed. is a longtime leader in family medicine education and primary care development. He served as CEO of the Family Medicine Education Consortium (1994–2021), advancing collaboration across academic and primary care communities in the Northeast. He also held leadership roles at the Center for Innovation in Family and Community Health and served as Associate Clinical Professor at Wright State University, with prior faculty development positions at The Ohio State University and Penn State College of Medicine. Now an active consultant, he remains dedicated to building a primary-care–driven U.S. healthcare system. Based in Hershey, PA, he enjoys time with family, pickleball, basketball, and gardening.
Appears in 1 episode
Len May
Guest
Len May
Len May is a pioneer in personalized wellness, combining over 25 years of experience in genomics, epigenetics, and the endocannabinoid system. As the CEO of EndoDNA, he leads the development of a patented platform that uses DNA to deliver personalized health insights, supported by the world’s largest real-world efficacy dataset. A global authority on medicinal cannabis and precision health, Len is also a published author, international speaker, and host of the podcast Everything is Personal. His books Making Cannabis Personal and ADD is a Superpower highlight his commitment to reshaping healthcare through personalization. Len’s work continues to shape the future of individualized medicine, making healthcare truly personal.
Appears in 1 episode
Marc Koska
Guest
Marc Koska
The inventor of the ApiJect Platform and its first BFS injection device is Marc Koska, a highly honored “social entrepreneur.” The Prefilled ApiJect Injector is designed for simplicity: Just prior to injection, a fill-finished Blow-Fill-Seal container and intramuscular needle hub are push-twisted together by a healthcare professional. Leading ApiJect R&D, Marc and his team design drug delivery system prototypes that can reliably serve both advanced and developing markets. Through feedback from patients and healthcare providers, Marc has a deep understanding of customers and in building healthcare partnerships. This feedback is the foundation of ApiJect’s Platform to ensure our single-use prefilled injector and future devices meet the needs of all. The ApiJect Platform of drug delivery devices is designed to optimize manufacturing, warehousing, and transportation, using advanced technology, deliver cost efficiencies and accelerating time to market, and most importantly, save lives.
Appears in 1 episode
Mary Hames
Guest
Mary Hames
Mary Hames is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency.
Appears in 1 episode
Meghna Deshraj
Producer
Meghna Deshraj
Meghna Deshraj is the CEO and Founder of Bullzeye Growth Partners, a strategic consultancy that helps businesses scale sustainably and profitably. With a background spanning corporate strategy, IT, finance, and process optimization, she combines analytical rigor with creative execution to drive measurable results. Under her leadership, Bullzeye has generated over $580M in annual growth and more than $1B in client revenue, guiding organizations through large-scale integrations, business transformations, and organizational change initiatives. A Certified Six Sigma Black Belt, Meghna’s superpower lies in strategic marketing and growth consulting, helping businesses grow through innovation, efficiency, and strong, trusted partnerships.
Appears in 74 episodes
Michael Friend
Guest
Michael Friend
Michael Friend is a U.S. veteran and founder of the Minority Coalition for Precision Medicine (MCPM), dedicated to ensuring precision medicine serves all communities, not just the privileged few. Inspired by his East Baltimore roots and the legacy of Henrietta Lacks, Michael fights for health equity through coalition-building, youth education, and advocacy in areas like CRISPR, sickle cell disease, and microbiome science. His work is a mission of justice, remembrance, and redemption, amplifying voices long ignored in healthcare.
Appears in 1 episode
Michael Gorton
Guest
Michael Gorton
Michael Gorton is a 15-time entrepreneur, author, and pioneer in telemedicine and digital health. As the founder of Teladoc—the world’s largest telemedicine company—he helped ignite a half-trillion-dollar industry. With degrees in engineering and law, Michael has built a career turning bold ideas into reality through ventures spanning healthcare, energy, and technology. A bestselling author and frequent keynote speaker, he continues to inspire innovation and leadership through his writing, public speaking, and mentorship of emerging entrepreneurs.
Appears in 1 episode
 Michele Hart
Guest
Michele Hart
Michele Hart is a strategic and creative communications leader with a proven ability to align business goals with marketing strategy and optimize resources for maximum impact. With extensive experience in the nonprofit and healthcare sectors, she develops high-performing campaigns that engage both B2B and B2C audiences, drive growth, and expand access to meaningful solutions. Her work has been featured in leading outlets including The New York Times, The Boston Globe, Good Housekeeping, TIME, and Prevention Magazine.
Appears in 1 episode
Naomi Cosman
Guest
Naomi Cosman
Naomi Cosman is the Global Head of Marketing at Koning, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin-Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School. She brings over a decade of experience—five years at a Fortune 500 company in branding and campaign management, followed by five years with startups across various sectors. At Koning, Naomi partners with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare.
Appears in 1 episode
Patti Aha
Guest
Patti Aha
Patti Aha is the CEO of the Robin Hill Group and a seasoned project management and business leader with a strong scientific foundation. With deep experience across operations, portfolio management, and process development, she excels at bringing structure, efficiency, and clarity to complex initiatives. Patti is passionate about effective leadership, transparent communication, and building collaborative teams that consistently deliver results. Her unique blend of scientific rigor and business acumen allows her to bridge the gap between technical and strategic domains, making her a trusted partner for organizations seeking operational excellence and sustainable growth.
Appears in 1 episode
Raymond Rodriguez-Torres
Guest
Raymond Rodriguez-Torres
Raymond Rodriguez-Torres is a bestselling author, acclaimed keynote speaker, and former executive with global organizations including Sanofi-Aventis, Genentech, and Hoffman-La Roche. A TEDx speaker, his talk Tragedy to Triumph: Live Like Bella ranks #2 worldwide on YouTube. Raymond has led teams of over 150 and managed sales exceeding $300 million. In memory of his daughter Bella, he serves as Chairman of the Live Like Bella® Foundation, which has funded millions for childhood cancer research and supported families in 38 countries. Raymond donates 100% of his book proceeds to pediatric cancer research and charity. A graduate of the University of Florida and Master’s in Management from Oral Roberts University, Raymond is also a licensed Master U.S. Coast Guard Captain, a maritime consultant, and a trained life coach. His work has earned him national and international recognition, including being named one of the most influential Hispanic leaders by Univision and one of “Florida’s Heroes” by Gov. Ron DeSantis.
Appears in 1 episode
Real Rousseau
Guest
Real Rousseau
Real Rousseau is a seasoned business growth strategist with over 20 years of executive leadership experience spanning CEO, COO, and Business Development roles. He specializes in helping companies unlock revenue potential, streamline operations, and lead high-performing sales and marketing teams. Known for delivering measurable results—such as doubling revenue and boosting profit margins by 30% in just 12 months—Real combines strategic vision with operational expertise to drive sustainable business success.
Appears in 1 episode
Rob Boyce
Guest
Rob Boyce
Rob Boyce is the CEO of Plakous Therapeutics, Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies. Prior to Plakous Rob was at Imago Systems, Inc., a software as a service medical diagnostic company seeking to redefine the medical imaging. He started his business career at Johnson & Johnson, marketing the Tylenol Brand. While at J&J he led worldwide Sales and Marketing for Independence Technology, a Johnson & Johnson company specializing in state-of-the-art rehabilitation technology. Rob launched his career as a naval flight officer in the Navy’s E-2C Hawkeye.
Appears in 1 episode
Sarah Bellenger
Guest
Sarah Bellenger
Sarah Bellenger is a clinician, Army veteran, and healthcare leader with over two decades of experience in patient care, team leadership, and system-wide operations. Her career spans cardiac ICU nursing, managing anesthesia teams across the U.S. and abroad, and even supporting executive health at the White House. After earning her MBA and serving in multiple leadership roles, Sarah recognized a recurring problem: capable professionals were burning out—not from the work itself, but from the inefficiencies surrounding it. Driven by her own experiences, including losing critical credentials during frequent relocations, Sarah founded ManageYou—a mobile app that helps healthcare professionals and teams centralize documents, track deadlines, and simplify renewals. Her mission is clear: to reduce administrative burdens so clinicians can focus on what matters most—caring for patients.
Appears in 1 episode
Sona Shah
Guest
Sona Shah
Sona Shah is the CEO and Co-Founder of Neopenda, where she leads the development of innovative medical technologies designed for low-resource healthcare settings. Inspired by her time teaching in Kenya and her background in biomedical engineering, Sona co-founded Neopenda in 2015 to help close critical gaps in care across emerging markets. Today, she and her team are bringing solutions like the neoGuard monitoring system to countries such as Kenya, Uganda, and Ghana—advancing accessible, tech-driven healthcare for the next billion people.
Appears in 1 episode
Stefan Lukianov
Guest
Stefan Lukianov
Stefan Lukianov is an artist, author, educator, businessman, and scientist with a background in computational bioengineering. He is the founder and CEO of Salve Therapeutics, where he is dedicated to advancing patient care through innovative viral and biologic therapies powered by advanced software solutions. His work centers on patient empowerment, with a focus on leveraging real-time health data and mobile health technologies to improve self-management, independence, and access to care. Beyond his role at Salve, Stefan is a strong advocate for mentorship and collaboration in the biotech industry, aiming to foster innovation, thoughtfulness, and a more patient-centered future for healthcare.
Appears in 1 episode
Stephanie Dorwart
Guest
Stephanie Dorwart
Stephanie Dorwart is the CEO of ALTIUS, a healthcare consulting firm she rebranded and now leads with a hands-on, results-driven approach. With over 15 years of experience in performance improvement and labor management, she’s worked with hospitals of all sizes—from rural facilities to large academic medical centers—helping them improve financial performance, patient outcomes, and staff satisfaction. Known for her analytical expertise and deep industry insight, Stephanie consistently delivers measurable ROI and lasting client impact.
Appears in 1 episode
Steve Schutzer
Guest
Steve Schutzer
Steve Schutzer is an orthopedic surgeon specializing in adult hip and knee reconstruction, with decades of experience leading joint replacement programs and advancing value-based orthopedic care. He believes in the power of connected communities and digital technologies—especially in today’s accelerating AI environment—working alongside compassionate human caregivers to solve complex medical challenges. Recognized as a focused, innovative, and visionary healthcare physician leader and strategist, Steve has an enduring obsession with improving the patient experience.
Appears in 1 episode
T.K. Martin Tsui
Guest
T.K. Martin Tsui
T.K. Martin Tsui is the Founder & CEO of ncrspt, a biotech platform pioneering the preservation of digital data in living cells using DNA-based storage technology. Under his leadership, ncrspt is developing proprietary methods to encode any digital format into biological systems for secure, long-term archiving across industries including healthcare, government, and enterprise. Tsui has a background in structural biochemistry and CRISPR research, with a Ph.D. in Molecular Biophysics and experience applying cutting-edge molecular biology techniques to solve complex scientific challenges before turning to deep tech entrepreneurship.
Appears in 1 episode
Trace Voshell
Guest
Trace Voshell
Trace Voshell is the Chief Revenue Officer of GoGoMeds, a company transforming pharmacy pricing by moving beyond traditional PBM models. After a decade in a large PBM-owned pharmacy, Trace shifted to the cash-pay side to make medications more affordable through a transparent, cost-plus pricing model. GoGoMeds empowers employers, physicians, and digital health companies to deliver medicine fairly, save money, and put patients first.
Appears in 1 episode
Tricia Cooney
Editor
Tricia Cooney
Tricia Cooney is a communications and media professional with over 15 years of experience delivering excellence in client support, content creation, and multi-media production. With 8 years dedicated to media communications within First Nations and non-profit organizations, she brings a deep understanding of culturally sensitive storytelling and mission-driven outreach. Tricia is a strategic thinker known for her ability to multi-task, prioritize, and execute projects efficiently in remote and digital environments. She is highly resourceful and results-oriented, with hands-on experience in proposal writing and organizing successful fundraising events. A skilled content manager and intermediate-level video editor, Tricia is proficient in Adobe Creative Suite, Microsoft Office, and has working knowledge of Joomla!, WordPress, FTP, HTML, as well as Google and Facebook Analytics. She thrives in fast-paced settings where adaptability and initiative are key to getting things done.
Appears in 42 episodes
Vance Clement
Guest
Vance Clement
Vance Clement is the CEO and Co-Founder of Lineus Medical, bringing over 30 years of experience in the medical device industry. Since joining Lineus in 2015 and becoming CEO in 2018, he has guided the company’s growth and innovation. Previously, Vance led sales and marketing at BlueInGreen, where he quadrupled annual revenue, and held senior marketing roles at Mako Surgical, helping expand the company from a small orthopedic start-up to over $100M in sales. He also spent a decade at Smith & Nephew Orthopaedics and began his career at Wright Medical Technology. Vance holds a B.S. in Industrial Engineering from the University of Arkansas and an MBA from Christian Brothers University. He has been recognized as a C-Suite Leader (2021), a State Tech Leader (2022), and a Distinguished Engineering Alumni (2024).
Appears in 1 episode
Wendy Slone, Ph.D.
Guest
Wendy Slone, Ph.D.
Dr. Wendy Slone is the founder and CEO of bTECH Inc., where she leads the development of the Halcyon SMART Patch—a wearable healing technology designed to revolutionize chronic wound care. Inspired by her mother’s experience with diabetic ulcers, Dr. Slone combines personal passion with deep scientific expertise. She holds a Ph.D. in public policy, is pursuing a second doctorate in chemistry, and brings over 15 years of experience in data analytics and entrepreneurship. Her mission is clear: to transform outcomes for patients facing chronic wounds through innovation, science, and purpose-driven leadership.
Appears in 1 episode
Yuliana Mihaylova
Guest
Yuliana Mihaylova
Yuliana is a seasoned biotech executive and the team’s mission enforcer. After completing her Genetics PhD and post-doctoral research at the universities of Nottingham and Oxford, respectively, she worked in biotech and pharma management consulting, where she helped companies develop their asset commercialization and market access strategies. From 2019 to 2024, Yuliana was part of the executive team at Basepaws, a pet genetics company, acquired by the animal pharma startup Zoetis in 2022. As Basepaws’ Head of R&D, she led the development and refinement of new technologies and scientific products and was a key stakeholder in the translation of scientific discovery into business strategy. Yuliana believes strongly in the power of cross-disciplinary collaboration and innovative thinking to solve the world’s most pressing environmental challenges.
Appears in 1 episode